Contact

Analysis of investment in mHealth. Top Doctors doubles its turnover and expects to triple it in 2018.


, , , , , , , , ,
Integral service around a transaction
BY : Diego GutiérrezMarch Mon, 2018

We present the latest investment rounds in companies specialising in mHealth (Mobile Health) in Europe. In addition, we analyse the success of the Spanish company Top Doctors, which has doubled its turnover in 2017 and expects to triple it in 2018.

Get in touch with our experts.

We present the latest investment rounds in companies specialising in mHealth (Mobile Health) in Europe. In addition, we analyse the success of the Spanish company Top Doctors, which has doubled its turnover in 2017 and expects to triple it in 2018.

About Top Doctors

Top Doctors is a Spanish company that has developed an online platform to find and contact the best medical specialists in private healthcare, audited and certified by the most rigorous doctor selection process in the world.

With a unique business model, the company offers patients the latest tools for accessing the most prestigious national and international medical lists, while providing doctors with cutting-edge technological solutions, online presence and brand image.

The Top Doctors platform brings patients closer to top doctors, verified through certifications, audits and an exhaustive control of their professional careers. The doctor selection process of Top Doctors, in which Inveready participates, has 25 years of experience and is unique in the world.

"The future is online, the doctor must undoubtedly go digital and the patient has the right to be able to trust the internet," says Alberto E Porciani, CEO and Co-Founder of Top Doctors. "Therefore, the key in the process of digitalisation of the healthcare sector is to offer the patient a secure and quality access that gives them the necessary peace of mind to make a decision with guarantees. As a company and technological solution, it is our duty to provide sufficient information, check it, assess it, contrast it and manage it appropriately".

 

About Inveready

Established in 2008, Inveready is one of the largest seed capital funds in our country, which was created in 2008, in the midst of the crisis and so far has raised six funds worth more than €60M. Inveready is committed to technology-based companies, especially in the field of ICT and biotechnology. Its investments typically range from €200k to €200M.

Inveready Technology Investment Group is one of the leading venture capital firms in Spain. With six investment funds to date and €92M under management, Inveready invests in technology companies with high growth potential and innovative business models, particularly in the field of biotechnology.

The firm has extensive experience in different areas, with a portfolio of more than 80 leading companies in their respective markets.

CORPORATE FINANCE EXPERTS

Top Doctors, owned by Inveready, doubles and triples its turnover

The Spanish company Top Doctors, an online platform for finding and contacting the best medical specialists in private healthcare, audited and certified by the most rigorous doctor selection process in the world, has doubled its turnover in 2017 with more than $7M in the European and Latin American market.

The company is doubling figures for the fourth year in a row and expects to triple them in 2018, a year for which it has set a target of $20M.

After three rounds of financing, Top Doctors has an accumulated capital of €4.1M, of which a very significant part is being allocated to technological innovation. "We are preparing to offer new services to doctors and patients through the website and the App, which will position us as the benchmark company in the Digital Health sector".

In addition, Top Doctors will enter two new markets this year, one in Europe and the other in Latin America, which will be added to those already consolidated: Spain, Italy, the United Kingdom, Mexico, Colombia, Chile and the USA.

The company currently has more than 60,000 professionals from all medical specialties globally, with a 50% increase in the number of members in the last year. Its platform has also doubled the number of patient visits - more than 20 million - who have booked up to 1 million appointments with their doctors.

 

Analysis of mHealth investment

Here are the latest investment rounds in the mHealth (Mobile Health) sector in Europe:

 

PROGRAMMEERDF - Innterconecta
PUBLIC BODYCDTI - Ministry of Economy, Industry and Competitiveness
BENEFICIARIESThe beneficiaries will have to have a place of development of their activities in the following ACs:
- Phase 1 : Andalusia, Castilla-La Mancha, Castilla-León, Canary Islands, Extremadura and Murcia.
- Phase 2: Andalusia, Extremadura, Galicia and Valencia.

Phase 1 will take place in 2018 and Phase 2 in 2019.
PURPOSE OF THE PROGRAMMEStimulate stable cooperation in R&D activities between companies located in the target regions of the "Smart Growth Operational Programme 2014-2020".

It pursues the development of novel technologies in technological areas of the future with international economic and commercial projection, while at the same time representing a relevant technological and industrial advance for these regions.

It will mobilise the participation of SMEs in associative projects of a certain size.

The themes of the projects will be aligned with the Societal Challenges and the priorities of the Smart Growth Operational Programme 2014-2020:
- Health, demographic change and well-being.
- Food safety and quality; productive and sustainable agriculture, natural resources, marine and maritime research.
- Safe, efficient and clean energy.
- Intelligent, sustainable and integrated transport.
- Action on climate change and efficiency in the use of resources and raw materials.
- Social changes and innovations.
- Digital economy and society.
- Security, safety and defence.
CHARACTERISTICS OF THE AIDThey are cooperative projects. The groupings must be made up of at least two autonomous enterprises, of which at least one must be large or medium-sized and the other must be an SME.
The maximum number of member companies of the Consortium will be 6.

The entities must sign a Consortium Agreement (if not finalised at the time of submission, it may be submitted prior to the Project Resolution), the minimum content of which is as follows:
- None of the autonomous companies, nor any group of related or associated companies may exceed 70% of the bankable budget of the project.
- The project activities to be subcontracted do not necessarily have to be carried out within the above-mentioned ACs.
- The overall cost of the subcontracted activity for each beneficiary cannot exceed 50% of its budget.
TYPES OF AIDThe aid is a non-repayable grant. The maximum aid intensity will be:
- Large companies: 40%
- Medium-sized enterprises: 50%
- Small business: 60%

Type of financing
The support is co-financed by ERDF funds through the "Smart Growth Operational Programme 2014-2020". The remainder will be financed by CDTI's own funds.

Project budget
Between €1M and €4M.

Eligible expenditure
- Personnel costs: personnel registered in the Autonomous Community where the project activities are carried out.
- Costs of purchase of equipment, instruments and material: only depreciation for the duration of the project.
- Consumables.
- Costs of contractual research, know-how and patents acquired or licensed from external sources at arm's length.
- Audit: if the company is obliged to have its accounts audited, the review of the supporting account may be carried out by the same or another auditor, provided that he/she is registered with the ROAC. The maximum amount eligible for funding is €2,000 per beneficiary and per year.
DEADLINEOPEN - 03/05/2018 a 05/06/2018
INFORMATION+34 946 42 41 42

info@abra-invest.com

Other posts that may interest you

Atrys Health closes the second largest capital increase on the MAB

New funds in November: MCH, ICG, Inveready and HealthEquity

The e-health company Docplanner, which merged last year with the Catalan company Doctoralia, receives €15 million.

Yes looking for investors, you want to buy or sell your company or finance your R&D&I project, get in touch with our Corporate Finance experts.

If you are looking for investors, want to buy or sell your company or finance your R&D&I project, contact our Corporate Finance experts.

Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?

M&A NEWS
INDUSTRIAL REPORTS
closearrow-circle-o-downchevron-downcrossmenu